Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose
- Author
- HADZIYANNIS, Stephanos J1 ; SETTE, Hoel JR; ZEUZEM, Stefan; POCKROS, Paul J; LIN, Amy; ACKRILL, Andrew M; MORGAN, Timothy R; VIJAYAN BALAN; DIAGO, Moises; MARCELLIN, Patrick; RAMADORI, Giuliano; BODENHEIMER, Henry JR; BERNSTEIN, David; RIZZETTO, Mario
[1] Department of Medicine and Hepatology, Henry Dunant Hospital, 107 Mesoghion Avenue, Athens 11526, Greece
PEGASYS International Study Group - Source
Annals of internal medicine. 2004, Vol 140, Num 5, pp 346-355, 10 p ; ref : 21 ref
- CODEN
- AIMEAS
- ISSN
- 0003-4819
- Scientific domain
- General medicine general surgery
- Publisher
- American College of Physicians, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiviral Association médicamenteuse Chimiothérapie Chronique Dose Durée Homme Hépatite virale C Médecine Peginterféron alfa-2a Randomisation Ribavirine Traitement associé Analogue nucléoside Appareil digestif pathologie Foie pathologie Infection Virose
- Keyword (en)
- Antiviral Drug combination Chemotherapy Chronic Dose Duration Human Viral hepatitis C Medicine Peginterferon alfa-2a Randomization Ribavirin Combined treatment Nucleosidic analog Digestive diseases Hepatic disease Infection Viral disease
- Keyword (es)
- Antiviral Asociación medicamentosa Quimioterapia Crónico Dosis Duración Hombre Hepatitis virica C Medicina Peginterferón alfa-2a Aleatorización Ribavirina Tratamiento asociado Análogo nucleósido Aparato digestivo patología Hígado patología Infección Virosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02F Viral diseases of the digestive system
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02G Viral hepatitis
- Discipline
- Generalities in medical sciences Infectious pathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15518409
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.7326/0003-4819-140-5-200403020-00010 
https://dx.doi.org/10.7326/0003-4819-140-5-200403020-00010
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:39:\"10.7326\/0003-4819-140-5-200403020-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"140\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"346\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"HADZIYANNIS\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Stephanos J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"SETTE, Hoel JR\";i:1;s:14:\"ZEUZEM, Stefan\";i:2;s:15:\"POCKROS, Paul J\";i:3;s:8:\"LIN, Amy\";i:4;s:17:\"ACKRILL, Andrew M\";i:5;s:17:\"MORGAN, Timothy R\";i:6;s:13:\"VIJAYAN BALAN\";i:7;s:13:\"DIAGO, Moises\";i:8;s:18:\"MARCELLIN, Patrick\";i:9;s:18:\"RAMADORI, Giuliano\";i:10;s:21:\"BODENHEIMER, Henry JR\";i:11;s:16:\"BERNSTEIN, David\";i:12;s:15:\"RIZZETTO, Mario\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:39:\"10.7326\/0003-4819-140-5-200403020-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"140\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"346\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"HADZIYANNIS\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Stephanos J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"SETTE, Hoel JR\";i:1;s:14:\"ZEUZEM, Stefan\";i:2;s:15:\"POCKROS, Paul J\";i:3;s:8:\"LIN, Amy\";i:4;s:17:\"ACKRILL, Andrew M\";i:5;s:17:\"MORGAN, Timothy R\";i:6;s:13:\"VIJAYAN BALAN\";i:7;s:13:\"DIAGO, Moises\";i:8;s:18:\"MARCELLIN, Patrick\";i:9;s:18:\"RAMADORI, Giuliano\";i:10;s:21:\"BODENHEIMER, Henry JR\";i:11;s:16:\"BERNSTEIN, David\";i:12;s:15:\"RIZZETTO, Mario\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:39:\"10.7326\/0003-4819-140-5-200403020-00010\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:39:\"10.7326\/0003-4819-140-5-200403020-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"140\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"346\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"HADZIYANNIS\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Stephanos J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"SETTE, Hoel JR\";i:1;s:14:\"ZEUZEM, Stefan\";i:2;s:15:\"POCKROS, Paul J\";i:3;s:8:\"LIN, Amy\";i:4;s:17:\"ACKRILL, Andrew M\";i:5;s:17:\"MORGAN, Timothy R\";i:6;s:13:\"VIJAYAN BALAN\";i:7;s:13:\"DIAGO, Moises\";i:8;s:18:\"MARCELLIN, Patrick\";i:9;s:18:\"RAMADORI, Giuliano\";i:10;s:21:\"BODENHEIMER, Henry JR\";i:11;s:16:\"BERNSTEIN, David\";i:12;s:15:\"RIZZETTO, Mario\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:39:\"10.7326\/0003-4819-140-5-200403020-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"140\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"346\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"HADZIYANNIS\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Stephanos J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"SETTE, Hoel JR\";i:1;s:14:\"ZEUZEM, Stefan\";i:2;s:15:\"POCKROS, Paul J\";i:3;s:8:\"LIN, Amy\";i:4;s:17:\"ACKRILL, Andrew M\";i:5;s:17:\"MORGAN, Timothy R\";i:6;s:13:\"VIJAYAN BALAN\";i:7;s:13:\"DIAGO, Moises\";i:8;s:18:\"MARCELLIN, Patrick\";i:9;s:18:\"RAMADORI, Giuliano\";i:10;s:21:\"BODENHEIMER, Henry JR\";i:11;s:16:\"BERNSTEIN, David\";i:12;s:15:\"RIZZETTO, Mario\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:39:\"10.7326\/0003-4819-140-5-200403020-00010\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"140\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"346\";s:8:\"\u0000*\u0000epage\";s:3:\"355\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"HADZIYANNIS\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Stephanos J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:14:\"SETTE, Hoel JR\";i:1;s:14:\"ZEUZEM, Stefan\";i:2;s:15:\"POCKROS, Paul J\";i:3;s:8:\"LIN, Amy\";i:4;s:17:\"ACKRILL, Andrew M\";i:5;s:17:\"MORGAN, Timothy R\";i:6;s:13:\"VIJAYAN BALAN\";i:7;s:13:\"DIAGO, Moises\";i:8;s:18:\"MARCELLIN, Patrick\";i:9;s:18:\"RAMADORI, Giuliano\";i:10;s:21:\"BODENHEIMER, Henry JR\";i:11;s:16:\"BERNSTEIN, David\";i:12;s:15:\"RIZZETTO, Mario\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
